Literature DB >> 10948394

Pharmacokinetics tricks and traps: flip-flop models.

H Boxenbaum1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 10948394

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN： 1482-1826            Impact factor:   2.327


× No keyword cloud information.
  13 in total

1.  Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.

Authors:  Miia Kovalainen; Juha Mönkäre; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto; Karl-Heinz Herzig; Kristiina Järvinen
Journal:  Pharm Res       Date:  2011-10-27       Impact factor: 4.200

Review 2.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

Review 3.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

4.  Coupled solutions of one- and two-compartment pharmacokinetic models with first-order absorption.

Authors:  N Asmanova; G Koloskov; A I Ilin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-10       Impact factor: 2.745

5.  Evaluation and synthesis of polar aryl- and heteroaryl spiroazetidine-piperidine acetamides as ghrelin inverse agonists.

Authors:  Suvi T M Orr; Ramsay Beveridge; Samit K Bhattacharya; Kimberly O Cameron; Steven Coffey; Dilinie Fernando; David Hepworth; Margaret V Jackson; Vishal Khot; Rachel Kosa; Kimberly Lapham; Paula M Loria; Kim F McClure; Jigna Patel; Colin Rose; James Saenz; Ingrid A Stock; Gregory Storer; Maria von Volkenburg; Derek Vrieze; Guoqiang Wang; Jun Xiao; Yingxin Zhang
Journal:  ACS Med Chem Lett       Date:  2014-12-14       Impact factor: 4.345

6.  Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures.

Authors:  Frederick S Vom Saal; Catherine A VandeVoort; Julia A Taylor; Wade V Welshons; Pierre-Louis Toutain; Patricia A Hunt
Journal:  Reprod Toxicol       Date:  2014-02-25       Impact factor: 3.143

7.  Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.

Authors:  John F R Robertson; Bjorn Erikstein; Kent C Osborne; John Pippen; Steven E Come; Leroy M Parker; Stan Gertler; Mike P Harrison; David A Clarke
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs.

Authors:  Lilia Gutiérrez; Zazil-Ha Velasco; Carlos Vázquez; Dinorah Vargas; Héctor Sumano
Journal:  Acta Vet Scand       Date:  2012-06-08       Impact factor: 1.695

9.  A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis.

Authors:  Himanshu Naik; Max C Tsai; Jill Fiedler-Kelly; Ping Qiu; Majid Vakilynejad
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Pharmacokinetics of a peroral single dose of two long-acting formulations and an aqueous formulation of doxycycline hyclate in horses.

Authors:  Heidi Zozaya; Lilia Gutierrez; Maria Josefa Bernad; Hector Sumano
Journal:  Acta Vet Scand       Date:  2013-03-08       Impact factor: 1.695
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.